Immunological and short-term brain volume changes in relapsing forms of multiple sclerosis treated with interferon beta-1a subcutaneously three times weekly: an open-label two-arm trial

Exploring the origins of grey matter damage in multiple sclerosis

(2015) Massimiliano Calabrese et al.   NATURE REVIEWS NEUROSCIENCE

Clinical Relevance of Brain Volume Measures in Multiple Sclerosis

(2014) Nicola De Stefano et al.   CNS DRUGS

Effect of Treatment with Interferon Beta-1a on Changes in Voxel-Wise Magnetization Transfer Ratio in Normal Appearing Brain Tissue and Lesions of Patients with Relapsing–Remitting Multiple Sclerosis: A 24-Week, Controlled Pilot Study

(2014) Robert Zivadinov et al.   PLoS One

Preventing brain atrophy should be the gold standard of effective theraphy in MS (after the first year of treatment): No

(2013) M Filippi et al.   Multiple Sclerosis Journal

Early brain pseudoatrophy while on natalizumab therapy is due to white matter volume changes

(2013) Angela Vidal-Jordana et al.   Multiple Sclerosis Journal

Improved longitudinal gray and white matter atrophy assessment via application of a 4-dimensional hidden Markov random field model

(2013) Michael G. Dwyer et al.   NEUROIMAGE

Clinical correlates of grey matter pathology in multiple sclerosis

(2012) Dana Horakova et al.   BMC Neurology

Clinical applications of imaging disease burden in multiple sclerosis: MRI and advanced imaging techniques

(2012) Claire Riley et al.   Expert Review of Neurotherapeutics

Measurement and clinical effect of grey matter pathology in multiple sclerosis

(2012) Jeroen JG Geurts et al.   LANCET NEUROLOGY

Natalizumab strongly suppresses cortical pathology in relapsing–remitting multiple sclerosis

(2012) F Rinaldi et al.   Multiple Sclerosis Journal

Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria

(2011) Chris H. Polman et al.   ANNALS OF NEUROLOGY

Effect of disease-modifying therapies on brain volume in relapsing–remitting multiple sclerosis: Results of a five-year brain MRI study

(2011) Omar Khan et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

A case of multiple sclerosis presenting with inflammatory cortical demyelination

(2011) B. F. G. Popescu et al.   NEUROLOGY

Inflammatory Cortical Demyelination in Early Multiple Sclerosis

(2011) Claudia F. Lucchinetti et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cortical Lesions and Atrophy Associated With Cognitive Impairment in Relapsing-Remitting Multiple Sclerosis

(2009) Massimiliano Calabrese et al.   ARCHIVES OF NEUROLOGY

IFN-  Inhibits Human Th17 Cell Differentiation

(2009) V. S. Ramgolam et al.   JOURNAL OF IMMUNOLOGY

Persistent T1 hypointensity as an MRI marker for treatment efficacy in multiple sclerosis

(2008) IJ van den Elskamp et al.   Multiple Sclerosis Journal

Poster Presentations

(2008)   Multiple Sclerosis Journal

Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosis

(2008) R. Zivadinov et al.   NEUROLOGY